abstract |
The present invention is an inhibitor of huTNFRI receptor, which is a human or humanized antibody construct which monovalently recognizes huTNFRI through an antigen-binding portion characterized by a specific CDR sequence, a pharmaceutical preparation thereof, producing said inhibitor Methods and medical uses of the inhibitors. |